Export 290 results:
Author Title Type [ Year
Filters: First Letter Of Title is P [Clear All Filters]
“Patient Perceptions of Three Substance Use Screening Tools for Use During Pregnancy.”, Matern Child Health J, 2022.
, “A phase 1 dose-sparing, randomized clinical trial of seasonal trivalent inactivated influenza vaccine combined with MAS-1, a novel water-in-oil adjuvant/delivery system.”, Vaccine, vol. 40, no. 9, pp. 1271-1281, 2022.
, , “Performance of a single-use, rapid, point-of-care PCR device for the detection of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis: a cross-sectional study.”, Lancet Infect Dis, vol. 21, no. 5, pp. 668-676, 2021.
, “PfSPZ-CVac efficacy against malaria increases from 0% to 75% when administered in the absence of erythrocyte stage parasitemia: A randomized, placebo-controlled trial with controlled human malaria infection.”, PLoS Pathog, vol. 17, no. 5, p. e1009594, 2021.
, “Pharmacokinetic and Pharmacodynamic Profiling of Minocycline for Injection following a Single Infusion in Critically Ill Adults in a Phase IV Open-Label Multicenter Study (ACUMIN).”, Antimicrob Agents Chemother, vol. 65, no. 3, 2021.
, “PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.”, Addict Sci Clin Pract, vol. 16, no. 1, p. 9, 2021.
, “Patient characteristics and long-term outcomes beyond the first 6 months after a diagnosis of cancer-associated venous thromboembolism.”, Thromb Res, vol. 188, pp. 106-114, 2020.
, “Patient-Reported Outcomes and Frailty Among Participants in the NHLBI MDS Natural History Study”, in 62nd ASH Annual Meeting and Exposition, 2020.
, “Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open Label Phase 1 Multiple Ascending Dose and Food Effect Study.”, Antimicrob Agents Chemother, 2020.
, “Plasmablast, Memory B Cell, CD4+ T Cell, and Circulating Follicular Helper T Cell Responses to a Non-Replicating Modified Vaccinia Ankara Vaccine.”, Vaccines (Basel), vol. 8, no. 1, 2020.
, “Population Pharmacokinetics of Metoclopramide in Infants, Children, and Adolescents.”, Clin Transl Sci, 2020.
, “Population pharmacokinetics of olanzapine in children.”, Br J Clin Pharmacol, 2020.
, “A population-based approach to reporting system-level performance measures for rheumatoid arthritis care.”, Arthritis Care Res (Hoboken), 2020.
, “Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola.”, Emerg Infect Dis, vol. 26, no. 3, pp. 541-548, 2020.
, “Prenatal Practice Staff Perceptions of Three Substance Use Screening Tools for Pregnant Women.”, J Addict Med, vol. 14, no. 2, pp. 139-144, 2020.
, , “Prevalence of obesity among U.S. population with substance dependence.”, Drug Alcohol Depend, vol. 217, p. 108293, 2020.
, “A Prospective Cohort Study to Evaluate the Impact of Diet, Exercise, and Lifestyle on Fertility (IDEAL): Design and Baseline Characteristics.”, Am J Epidemiol, 2020.
, “Proteomic Analysis of Human Immune Responses to Live-Attenuated Tularemia Vaccine.”, Vaccines (Basel), vol. 8, no. 3, 2020.
, “Partnering, Not Enduring: Citizen Science and Research Participation.”, Am J Bioeth, vol. 19, no. 9, pp. 44-45, 2019.
, , “Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Volunteers: a Randomized, Placebo-Controlled First-in-Human Single-Dose Escalation Study.”, Antimicrob Agents Chemother, vol. 63, no. 4, 2019.
, “A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.”, Vaccine, vol. 37, no. 4, pp. 602-611, 2019.
, ,